If you are having trouble viewing this email, please view it on our website

A Service Announcement from Pharmexec
Pharmaceutical Executive

   

EvaluatePharma


New Report
World Preview 2018 - Embracing the Patent Cliff

We've just released our industry leading annual report - download your copy of World Preview 2018 now.

Based on EvaluatePharma's coverage of the world's leading 3,500 pharmaceutical and biotech companies, World Preview 2018 highlights forecast trends in:

  • Worldwide prescription drug sales
  • Patent risk
  • Global brand sales
  • R&D spend
  • Market performance by therapy area
  • Plus a review of 2011 performance
  • New geographical analysis of market performance of US, Europe and Japan in 2011

This latest edition of our complimentary report offers valuable insights into which companies and products will come out as winners.

Sincerely,

The EvaluatePharma Team

 




Download World Preview 2018

EvaluatePharma World Preview 2018 reveals more than $290 billion of prescription drug sales are at risk from patent expirations 2012-2018 and offers an in-depth look at how the patent cliff will reshape the drug industry over the next six years.

 

World Preview 2018




 

If you no longer wish to receive emails from EvaluatePharma Ltd then click here to unsubscribe.

EvaluatePharma Ltd 11-29 Fashion Street London E1 6PX United Kingdom
EvaluatePharma Ltd registered in England and Wales, company registration number 5876322

Pharmaceutical Executive is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ
This is an advertisement sent on behalf of this advertiser.